Anal cancer, primarily squamous cell carcinoma, remains under-addressed compared to other cancers, yet its incidence is increasing due to HPV prevalence, HIV co-infection, and demographic shifts. The market encompasses medications such as chemotherapeutics, immunotherapies, and targeted agents used alone or in combination with surgery/radiation. Key growth stems from greater awareness,...